[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-336009-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-336009-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","regulation-of-cancer-stem-cells-by-cxcl1-a-chemokine-whose-secretion-is-controlled-by-mcm2","Regulation of cancer stem cells by CXCL1, a chemokine whose secretion is controlled by MCM2","","Background: Minichromosome maintenance 2 (MCM2) shows high expression across cancers and is a cell-cycle protein implicated in cancer growth and differentiation via the MCM family (MCM2–MCM7). MCM2 has been linked to cell-cycle control, cancer progression, and resistance, yet its role in cancer stem cell regulation remained insufficiently described. Methods: The study characterized cancer stem cells and examined regulation of epithelial-to-mesenchymal transition (EMT) in lung and glioma stem cells, focusing on MCM2-dependent secreted factors. Results: Survival differed by MCM2 expression; MCM2 regulated markers and regulatory proteins in lung cancer stem cells, and influenced metastasis-related migration and invasion. Among chemokines, CXCL1 was identified as regulated by MCM2. Conclusions: MCM2 supports malignant phenotypes by shaping a favorable external microenvironment, suggesting MCM2 as a potential therapeutic target.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/regulation-of-cancer-stem-cells-by-cxcl1-a-chemokine-whose-secretion-is-controlled-by-mcm2/336009/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/regulation-of-cancer-stem-cells-by-cxcl1-a-chemokine-whose-secretion-is-controlled-by-mcm2/336009.png","ImageObject",300,407,{"name":42,"@type":43},"Anda","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main focus of this study?","Question",{"text":63,"@type":64},"The study investigates how MCM2 regulates cancer stem cells, including epithelial-to-mesenchymal transition (EMT) and MCM2-controlled secreted factors, with attention to the chemokine CXCL1.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How is MCM2 related to cancer stem cells and EMT?",{"text":68,"@type":64},"MCM2 is shown to regulate markers and regulatory proteins in lung cancer stem cells and to be associated with processes tied to metastasis, including cell migration and invasion, which relate to EMT-linked behavior.",{"name":70,"@type":61,"acceptedAnswer":71},"Which chemokine was identified as regulated by MCM2?",{"text":72,"@type":64},"CXCL1 (chemokine (C-X-C motif) ligand 1) was found to be regulated by MCM2 among the chemokines examined.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},336009,1790015000,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":112,"preview_page_count":4},962075006959,"https://ap-avatar.wpscdn.com/avatar/e0002397efbe92a78e?_k=1776741047341049297","Kahm etal. BMC Cancer (2024) 24:319 [https://doi.org/10.1186/s12885-024-12085-0](https://doi.org/10.1186/s12885-024-12085-0)  \nBMC Cancer  \nRESEARCH Open Access  \nRegulation of cancer stem cells by CXCL1, a chemokine whose secretion is controlled by MCM2  \nYeon-Jee Kahm 1,2†, In-Gyu Kim 1,2 and Rae-Kwon Kim 1,2*†  \nAbstract  \nBackground A high expression pattern of minichromosome maintenance 2 (MCM2) has been observed in various cancers. MCM2 is a protein involved in the cell cycle and plays a role in cancer growth and differentiation by binding to six members of the MCM subfamily. The MCM protein family includes MCM2 through MCM7 .  \nMethods MCM2 has shown high expression in both lung cancer stem cells (LCSCs) and glioma stem cells (GSCs) . We investigated the characteristics of CSCs and the regulation of the epithelial-to-mesenchymal transition (EMT) phenomenon in LCSCs and GSCs by MCM2 . Additionally, we explored secreted factors regulated by MCM2 .  \nResults There was a significant difference in survival rates between lung cancer patients and brain cancer patients based on MCM2 expression. MCM2 was found to regulate both markers and regulatory proteins in LCSCs. Moreover, MCM2 is thought to be involved in cancer metastasis by regulating cell migration and invasion, not limited to lung cancer but also identified in glioma. Among chemokines, chemokine (C-X-C motif ) ligand 1 (CXCL1) was found to be regulated by MCM2 .  \nConclusions MCM2 not only participates in the cell cycle but also affects cancer cell growth by regulating the external microenvironment to create a favorable environment for cells. MCM2 is highly expressed in malignant carcinomas, including CSCs, and contributes to the malignancy of various cancers. Therefore, MCM2 may represent a crucial target for cancer therapeutics.  \nKeywords MCM2, CXCL1, Cancer stem cells, EMT, Chemokine  \n†Yeon-Jee Kahm and Rae-Kwon Kim contributed equally to this work.  \n*Correspondence: Rae-Kwon Kim [rkim@kaeri. re.kr](rkim@kaeri. re.kr)  \n1Department of Radiation Biology, Environmental Safety Assessment Research Division, Korea Atomic Energy Research Institute, 111, DaedeokDaero 989 Beon-Gil, Yuseong-Gu, 34057 Daejeon, Korea  \n2Department of Radiation Science and Technology, Korea University of Science and Technology, Yuseong-Gu, 34113 Daejeon, Korea  \nIntroduction  \nMinichromosome maintenance (MCM) proteins are known to be among the proteins regulating the cell cycle [1]. The MCM protein family consists of six types, from MCM2 to MCM7, and is a replication protein present in all eukaryotic cells from yeast to humans [2]. MCM2 plays an essential role in the initiation and elongation steps in DNA replication in the cell cycle [3]. Also, asa DNA replication licensing factor in the cell cycle, it is a protein that regulates only one replication in one cell cycle [4]. During cell proliferation, six types of MCM surround double-stranded DNA in the form of a  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creativecommons.org/l)icenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ([http://creativecommons.org/publicdomain/zero/1.0/](http://creativecommons.org/publicdom","cbCaiculE0gGN3xe","https://ap.wps.com/l/cbCaiculE0gGN3xe","pdf",5352628,12,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What is the main focus of this study?\",\"answer\":\"The study investigates how MCM2 regulates cancer stem cells, including epithelial-to-mesenchymal transition (EMT) and MCM2-controlled secreted factors, with attention to the chemokine CXCL1.\"},{\"question\":\"How is MCM2 related to cancer stem cells and EMT?\",\"answer\":\"MCM2 is shown to regulate markers and regulatory proteins in lung cancer stem cells and to be associated with processes tied to metastasis, including cell migration and invasion, which relate to EMT-linked behavior.\"},{\"question\":\"Which chemokine was identified as regulated by MCM2?\",\"answer\":\"CXCL1 (chemokine (C-X-C motif) ligand 1) was found to be regulated by MCM2 among the chemokines examined.\"}]","Regulation of cancer stem cells by CXCL1, a chemokine whose secretion is controlled by MCM2 | PDF",1790013151]